Premium
4D Molecular Therapeutics Inc (FDMT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Janus Henderson Group plc | Institution | 5 247 151 | 10,04% | US$ 52,52M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 5 049 779 | 9,66% | US$ 50,55M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 5 049 779 | 9,66% | US$ 50,55M | 2026-03-31 |
| BlackRock, Inc. | Institution | 4 145 303 | 7,93% | US$ 41,49M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 3 784 180 | 7,24% | US$ 37,88M | 2026-03-31 |
| Novo Holdings A/S | Institution | 3 650 737 | 6,98% | US$ 36,54M | 2026-03-31 |
| BVF Partners L.P. | Institution | 2 879 289 | 5,51% | US$ 28,82M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 2 707 875 | 5,18% | US$ 27,11M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 2 195 578 | 4,20% | US$ 21,98M | 2026-03-31 |
| Armistice Capital LLC | Institution | 2 000 000 | 3,83% | US$ 20,02M | 2026-03-31 |
| Dr. David Kirn | Initiés | 1 659 153 | 3,17% | US$ 16,61M | 2026-04-20 |
| Adage Capital Management, L.P. | Institution | 1 605 156 | 3,07% | US$ 16,07M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 440 287 | 2,76% | US$ 14,42M | 2026-03-31 |
| Federated Hermes, Inc. | Institution | 1 432 260 | 2,74% | US$ 14,34M | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 1 302 917 | 2,49% | US$ 13,04M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 1 093 101 | 2,09% | US$ 10,94M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 065 345 | 2,04% | US$ 10,66M | 2026-03-31 |
| Hillhouse Investment Management, Ltd. | Institution | 951 474 | 1,82% | US$ 9,52M | 2026-03-31 |
| Deutsche Asset & Wealth Management | Institution | 708 044 | 1,35% | US$ 7,09M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 609 900 | 1,17% | US$ 6,11M | 2024-12-31 |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | Institution | 601 161 | 1,15% | US$ 6,02M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 578 265 | 1,11% | US$ 5,79M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 555 829 | 1,06% | US$ 5,56M | 2026-03-31 |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Institution | 548 991 | 1,05% | US$ 5,50M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 522 823 | 1,00% | US$ 5,23M | 2026-03-31 |
| Parkman Healthcare Partners LLC | Institution | 522 577 | 1,00% | US$ 5,23M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 490 614 | 0,94% | US$ 4,91M | 2025-03-31 |
| RTW Investments, LP | Institution | 475 737 | 0,91% | US$ 4,76M | 2026-03-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 421 258 | 0,81% | US$ 4,22M | 2026-03-31 |
| JP Morgan Asset Management | Institution | 381 395 | 0,73% | US$ 3,82M | 2026-03-31 |
| Bank of America Corporation | Institution | 373 012 | 0,71% | US$ 3,73M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 342 034 | 0,65% | US$ 3,42M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 328 379 | 0,63% | US$ 3,29M | 2026-03-31 |
| Propel Bio Management, LLC | Institution | 309 990 | 0,59% | US$ 3,10M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 289 025 | 0,55% | US$ 2,89M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
